	Zysk Z Działalności Operacyjnej		Data
Abbott	USD 2.25B	73M	2025-12
Agenus	USD -13.31M	12.58M	2025-03
Agios Pharmaceuticals	USD -116.87M	10.19M	2025-09
Anika Therapeutics	USD -4.28M	32.1M	2025-03
Arrowhead Research	USD 40.81M	3.3M	2025-12
Enanta Pharmaceuticals	USD -23.54M	98.15M	2024-12
Halozyme Therapeutics	USD 217.92M	15.48M	2025-09
Heron Therapeutics	USD -5.66M	782K	2024-09
Insmed	USD -261.35M	7.48M	2025-09
Integra LifeSciences	USD 11.76M	13.07M	2025-09
Intrexon	USD -60.84M	26.62M	2024-06
J&J	USD 5.59B	1.81B	2025-12
Karyopharm Therapeutics	USD -31.28M	5M	2024-12
Ligand Pharmaceuticals	USD 158.89M	149.17M	2025-09
MacroGenics	USD 18.64M	55.4M	2025-09
Merit Medical Systems	USD 42.61M	4.41M	2025-09
Rigel Pharmaceuticals	USD 14.06M	13.61M	2024-09
Sangamo BioSciences	USD -33.51M	12.77M	2024-06
Sanofi	EUR 1.7B	2.17B	2025-12
Smith & Nephew	USD 440M	50M	2025-12
Stryker	USD 1.97B	609M	2025-12
Surmodics	USD -5.64M	276K	2024-09
Veracyte	USD 23.11M	8.8M	2025-09
Xencor	USD -47.52M	14.35M	2025-09
Zimmer Biomet Holdings	USD 302.9M	35.4M	2025-12

Anika Therapeutics Zysk Z Działalności Operacyjnej - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.